MRK MRK

Merck Share Price - MRK

76.18
1.27 (1.7%)
Upgrade to Real-Time
Regular Market
76.18
Volume 12,056,341
Bid Price
Ask Price
News (4)
Day High 76.91

Low
70.89

52 Week Range

High
91.40

Day Low 75.45
Best deals to access real time data!
USA CHART Trader
Monthly Subscription
for only
US$30.66
North American Extreme
Monthly Subscription
for only
US$104.50
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
VAT not included
Stock Name Stock Symbol Market Stock Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Price Change % Stock Price Last Trade
1.27 1.7% 76.18 12:15:46
Open Price Low Price High Price Close Price Previous Close
75.58 75.45 76.91 74.91
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
133,710 12,056,341 US$ 76.33 US$ 920,308,059 - 70.89 - 91.40
Last Trade Type Quantity Price Currency
12:15:46 100 US$ 76.18 USD

Period:

Draw Mode:

Merck and Co Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 192.43B 2.53B 2.52B US$ 48.00B US$ 8.71B 2.77 26.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ 2.48 3.47% 09/14/21 1.16k 0.10%

more financials information »

Merck News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week82.5582.9073.8476.4422,707,238-6.37-7.72%
1 Month88.9291.4073.8481.3815,258,166-12.74-14.33%
3 Months75.9791.4070.8979.5916,678,6300.210.28%
6 Months76.1291.4070.8978.2913,307,2320.060.08%
1 Year80.8891.4070.8977.9712,264,909-4.70-5.81%
3 Years79.5292.6465.2579.6010,845,689-3.34-4.2%
5 Years61.3092.6452.8373.2310,294,69614.8824.27%

Merck Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211201 18:30:46